2,154
Views
4
CrossRef citations to date
0
Altmetric
Cardiovascular Medicine

Contribution of single-pill combinations in the management of hypertension: perspectives from China, Europe and the USA

&
Pages 331-340 | Received 14 Dec 2022, Accepted 04 Jan 2023, Published online: 20 Jan 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Stefano Taddei, Nqoba Tsabedze & Ru-San Tan. (2024) β-blockers are not all the same: pharmacologic similarities and differences, potential combinations and clinical implications. Current Medical Research and Opinion 40:sup1, pages 15-23.
Read now
Felix Mahfoud, Jiguang Wang & Saumitra Ray. (2024) The current position of β-blockers in hypertension: guidelines and clinical practice. Current Medical Research and Opinion 40:sup1, pages 25-32.
Read now

Articles from other publishers (2)

Piotr Ryszkiewicz, Barbara Malinowska & Eberhard Schlicker. (2023) Polypharmacology: promises and new drugs in 2022. Pharmacological Reports 75:4, pages 755-770.
Crossref
Shuyang Zhang, Ying Li, Xin Xu, Rui Xu, Linchao Zhang, Xiaoqun Wan, Zhuhua Yao, Yuemin Sun, Yong Liu, Jianping Bin, Zhen Wang, Shuren Li, Ping Yang, Xiping Xu, Weidong Liang, Xiaohong Gao, Xiaodong Li, Min Jia, Guang Ma, Xiang Gu & Chang Hong. (2023) Efficacy and safety of single-pill amlodipine/losartan versus losartan in patients with inadequately controlled hypertension after losartan treatment: a multicenter, double-blind, randomized phase III clinical trial. Frontiers in Cardiovascular Medicine 10.
Crossref